Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $21,207 - $25,829
-1,007 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$16.77 - $24.71 $16,887 - $24,882
1,007 New
1,007 $24,000
Q1 2018

May 14, 2018

SELL
$16.68 - $22.07 $16,796 - $22,224
-1,007 Closed
0 $0
Q4 2017

Feb 06, 2018

SELL
$11.23 - $19.1 $943 - $1,604
-84 Reduced 7.7%
1,007 $19,000
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $16,812 - $35,097
1,091
1,091 $19,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Landaas & CO Portfolio

Follow Landaas & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Landaas & CO , based on Form 13F filings with the SEC.

News

Stay updated on Landaas & CO with notifications on news.